Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterologist)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (UK), FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (UK), FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), M.D
Consultant Physician
MBBS, FCPS
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Gastroenterologist
MBBS, MCPS, FCPS (Gastroenterology), FCPS (Medicine), MACG (USA)
Gastroenterologist
MBBS, MCPS, FCPS (Gastroenterology), FCPS (Medicine), MACG (USA)
Internal Medicine Specialist
M.B.B.S., M.D. (Medicine)
Diabetologist
MBBS, MRCP Medicine (UK), MRCP Diabetes & Endocrinology (UK), CCT Endocrinology & Diabetes (UK), FRCP (London), FRCP (Edin)
Diabetologist
MBBS, MRCP Medicine (UK), MRCP Diabetes & Endocrinology (UK), CCT Endocrinology & Diabetes (UK), FRCP (London), FRCP (Edin)
General Physician
MBBS, MRCP (Medicine) UK, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures